Literature DB >> 16385329

Durability of aneurysm embolization with matrix detachable coils.

David Fiorella1, Felipe C Albuquerque, Cameron G McDougall.   

Abstract

OBJECTIVE: Matrix detachable coils (MDC; Boston Scientific/Target, Fremont, CA) are platinum coils coated with a bioabsorbable polymeric material (polyglycolic-polylactic acid). In animal models, the introduction of polyglycolic-polylactic acid-coated coils into experimental aneurysms resulted in a cellular reaction which promoted stable intra-aneurysmal scar tissue formation. The current study was undertaken to assess the durability of aneurysm occlusion after embolization with MDC.
METHODS: All patients undergoing embolization were prospectively enrolled in an endovascular database at our institution. All coils used for embolization were recorded in the operative notes for the procedure. Only aneurysms embolized with 50% or greater length of MDC were included. All patients with Neuroform stents (Boston Scientific/Target, Fremont, CA) were excluded from the study. Patients were followed with conventional angiography and magnetic resonance angiography.
RESULTS: During a 20-month period, 131 aneurysms were embolized with MDC. Follow up data (average, 6.9 mo; range, 1.5-22 mo) were available for 82 aneurysms (61 with conventional angiography, 21 with magnetic resonance angiography only). Of the aneurysm patients with follow-up available, 65 had small aneurysms with small necks, three were small aneurysms with wide necks, 12 were large aneurysms, and two were giant aneurysms. Overall, there were 30 (36.6%) recanalizations, 19 (23.1%) of which required retreatment. In two additional patients, retreatment was either recommended (n = 1) or attempted unsuccessfully (n = 1). Fifty-two aneurysms were unchanged or demonstrated progressive thrombosis (63.4%). The recanalization rate for small aneurysms with small necks was 26.1% (17 out of 65) with a 13.8% retreatment rate (9/65). The recanalization rate for large aneurysms was 75% (9 out of 12) with seven requiring retreatment.
CONCLUSION: In the absence of Neuroform stent support, aneurysms embolized with the MDC system demonstrated a significant rate of recanalization. Many of the recanalizations were of sufficient size to warrant retreatment. The rates of recanalization observed in the present series were comparable to, or worse than, those reported for bare platinum coils.

Entities:  

Mesh:

Year:  2006        PMID: 16385329     DOI: 10.1227/01.neu.0000194190.45595.9e

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  37 in total

Review 1.  Review of 2 decades of aneurysm-recurrence literature, part 1: reducing recurrence after endovascular coiling.

Authors:  E Crobeddu; G Lanzino; D F Kallmes; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

2.  Bare, bio-active and hydrogel-coated coils for endovascular treatment of experimentally induced aneurysms. Long-term histological and scanning electron microscopy results.

Authors:  M H T Reinges; T Krings; A Y Drexler; A Ludolph; B Sellhaus; M Bovi; S Geibprasert; R Agid; K Scherer; F J Hans
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

3.  Endovascular treatment of intracranial aneurysms with matrix coils: immediate posttreatment results, clinical outcome and follow-up.

Authors:  T Jonas Kimchi; R A Willinsky; J Spears; S K Lee; K ter Brugge
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

4.  Matrix reloaded.

Authors:  H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

Review 5.  Materials and techniques for coiling of cerebral aneurysms: how much scientific evidence do we have?

Authors:  W Kurre; J Berkefeld
Journal:  Neuroradiology       Date:  2008-09-19       Impact factor: 2.804

6.  Development of microporous self-expanding stent grafts for treating cerebral aneurysms: designing micropores to control intimal hyperplasia.

Authors:  Shogo Nishi; Yasuhide Nakayama; Hatsue Ishibashi-Ueda; Yoshihiro Okamoto; Masato Yoshida
Journal:  J Artif Organs       Date:  2011-06-23       Impact factor: 1.731

Review 7.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

8.  Autologous adipose-derived mesenchymal stem cells improve healing of coiled experimental saccular aneurysms: an angiographic and histopathological study.

Authors:  Aymeric Rouchaud; Waleed Brinjikji; Daying Dai; Yong-Hong Ding; Tina Gunderson; Dana Schroeder; Laurent Spelle; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2017-01-11       Impact factor: 5.836

9.  Surgical and endovascular treatments for intracranial aneurysms.

Authors:  Bradley A Gross; Ziad A Hage; Marc Daou; Christopher C Getch; H Hunt Batjer; Bernard R Bendok
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

10.  Angiographic and histological comparison of canine bifurcation aneurysms treated with first generation matrix and standard GDC coils.

Authors:  Aquilla S Turk; Christopher M Luty; Victoria Carr-Brendel; Igor Polyakov; Dan Consigny; Julie Grinde; Rajat Mukherjee; Charles M Strother
Journal:  Neuroradiology       Date:  2007-09-27       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.